Cargando…
Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy
There are few effective treatment options for radiation-induced dermatitis in breast cancer patients. We conducted a single-arm trial to tested the hypothesis that topical epigallocatechin-3-gallate (EGCG) is effective against radiation-induced dermatitis in breast cancer patients undergoing radioth...
Autores principales: | Zhu, Wanqi, Jia, Li, Chen, Guanxuan, Zhao, Hanxi, Sun, Xiaorong, Meng, Xiangjiao, Zhao, Xianguang, Xing, Ligang, Yu, Jinming, Zheng, Meizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217042/ https://www.ncbi.nlm.nih.gov/pubmed/27224910 http://dx.doi.org/10.18632/oncotarget.9495 |
Ejemplares similares
-
Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial
por: Xie, Jingjing, et al.
Publicado: (2023) -
Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study
por: Zhu, Wanqi, et al.
Publicado: (2021) -
Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021) -
Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018) -
Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer
por: Meng, Xiangjiao, et al.
Publicado: (2015)